Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Lee, Jaewon James [1 ]
Yeh, Jen Jen [1 ,2 ,3 ]
机构：
[1] Univ North Carolina Chapel Hill, Dept Surg, 170 Manning Dr,CB7213, Chapel Hill, NC 27599 USA
[2] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr,CB7295, Chapel Hill, NC 27599 USA
来源：
SURGICAL CLINICS OF NORTH AMERICA | 2024年 / 104卷 / 05期
关键词：
Pancreatic cancer; Molecular subtyping; Cancer genomics; Next-generation sequencing; Precision oncology; CANCER; SUBTYPES; FIBROBLASTS; KRAS(G12D); INHIBITION; FOLFIRINOX; EFFICACY;
D O I：
10.1016/j.suc.2024.04.001
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：939 / 950
页数：12
相关论文
共 50 条
  • [21] Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma
    Resell, Mathilde
    Rabben, Hanne-Line
    Sharma, Animesh
    Hagen, Lars
    Hoang, Linh
    Skogaker, Nan T.
    Aarvik, Anne
    Bjastad, Eirik Knudsen
    Svensson, Magnus K.
    Amrutkar, Manoj
    Verbeke, Caroline S.
    Batra, Surinder K.
    Qvigstad, Gunnar
    Wang, Timothy C.
    Rustgi, Anil
    Chen, Duan
    Zhao, Chun-Mei
    SCIENTIFIC DATA, 2025, 12 (01)
  • [22] Genomic Profiling of Pancreatic Ductal Adenocarcinoma, Intrahepatic and Extrahepatic Cholangiocarcinoma
    Gosse, Matthew
    Sompallae, Ramakrishna
    Guseva, Natalya
    Snow, Anthony
    Bossler, Aaron
    Ma, Deqin
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1219 - 1221
  • [23] Genomic Profiling of Pancreatic Ductal Adenocarcinoma, Intrahepatic and Extrahepatic Cholangiocarcinoma
    Gosse, Matthew
    Sompallae, Ramakrishna
    Guseva, Natalya
    Snow, Anthony
    Bossler, Aaron
    Ma, Deqin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1219 - 1221
  • [24] Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines
    Kim, Yikwon
    Han, Dohyun
    Min, Hophil
    Jin, Jonghwa
    Yi, Eugene C.
    Kim, Youngsoo
    MOLECULES AND CELLS, 2014, 37 (12) : 888 - 898
  • [25] Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma
    Yasuda, Satoshi
    Nagai, Minako
    Terai, Taichi
    Kohara, Yuichiro
    Sho, Masayuki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (03): : 358 - 366
  • [26] Biomarker Discovery and Molecular Imaging of Pancreatic Ductal Adenocarcinoma
    Kelly, K.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [27] Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
    Shen, Quan
    Yu, Miao
    Jia, Jiang-Kun
    Li, Wen-Xi
    Tian, Yu-Wei
    Xue, Huan-Zhou
    MEDICAL SCIENCE MONITOR, 2018, 24 : 2368 - 2376
  • [28] Molecular Pathological Phenotypes and Outcome in Pancreatic Ductal Adenocarcinoma
    Jamieson, Nigel B.
    Mohamed, Mohamed A.
    Oien, Karin
    Duthie, Fraser
    Dickson, Euan J.
    Carter, Ross
    McKay, Colin
    GASTROENTEROLOGY, 2013, 144 (05) : S1059 - S1059
  • [29] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
    Qian, Yunzhen
    Gong, Yitao
    Fan, Zhiyao
    Luo, Guopei
    Huang, Qiuyi
    Deng, Shengming
    Cheng, He
    Jin, Kaizhou
    Ni, Quanxing
    Yu, Xianjun
    Liu, Chen
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [30] Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
    Taherian, Mehran
    Wang, Hua
    Wang, Huamin
    CELLS, 2022, 11 (19)
12345